The mRNA of CCDC69 was downregulated in breast cancer tissues compared with normal tissues. Higher CCDC69 expression was associated with a better breast cancer prognosis….Meanwhile, high CCDC69 expression can predict better immunotherapy responses when compared with low CCDC69 expression.